Company news
Qtrex Quantum Ltd. (NASDAQ:QTEX) news
Qtrex Quantum Ltd. news releases on 6ix. Latest, Jul 30, 2024: Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain…
Press releases — page 3
Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest
July 29, 2024
Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System
July 10, 2024
Inspira™ Announces Business Plan Targets
June 19, 2024
Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel
June 16, 2024
Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.
June 12, 2024
Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector
June 4, 2024
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
May 29, 2024
INSPIRA™ ART100 Receives FDA 510(k) Clearance
May 27, 2024
Inspira™ Announces Start of Production of the INSPIRA™ ART100
May 1, 2024
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
April 24, 2024
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
April 15, 2024
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
April 9, 2024
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
April 2, 2024
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
March 31, 2024
Inspira™ Technologies Reports Full Year 2023 Financial Results
March 24, 2024
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
March 17, 2024
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
March 11, 2024
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
March 3, 2024
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
February 26, 2024
Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
February 21, 2024
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
February 13, 2024
Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device
February 7, 2024
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
January 29, 2024
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
January 8, 2024
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
January 1, 2024
Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering
December 27, 2023
Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
December 25, 2023
Inspira Announces $3.88 Million Registered Direct Offering
December 25, 2023
In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil, to Medical Advisory Board
December 10, 2023
Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
November 28, 2023
Inspira™ Technologies Reports Third Quarter 2023 Financial Results
November 15, 2023
Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology
November 5, 2023
Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device
October 24, 2023
Inspira™ Terminates ATM Program and Provides an Update
October 23, 2023
Inspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUP
October 9, 2023
Inspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
September 27, 2023
Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization
September 12, 2023
Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices
August 28, 2023
Inspira™ Technologies Reports Second Quarter 2023 Financial Results
August 9, 2023
INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
August 8, 2023
Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval
July 23, 2023
Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.
July 18, 2023
Inspira Technologies Appoints Dr. Nir as Chief Medical Officer
May 29, 2023
Inspira™ Technologies Reports First Quarter 2023 Financial Results
May 17, 2023
Inspira™ Technologies will Reveal the New ALICE™ Device at the World's Largest Extracorporeal Life Support Conference
May 15, 2023
Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
May 10, 2023
Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
April 3, 2023
Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
March 21, 2023
Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
February 12, 2023
Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
January 22, 2023